Cargando…
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis
INTRODUCTION: Next‐generation sequencing (NGS) and digital polymerase chain reaction (PCR) based platforms have been used to detect EGFR mutations in plasma circulating tumor DNA (ctDNA) with high accuracy. Generally, molecular testing is performed after histopathological analysis. However, many pat...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064093/ https://www.ncbi.nlm.nih.gov/pubmed/31991049 http://dx.doi.org/10.1002/cam4.2869 |